# About CJC-1295 Ipamorelin Reviews: An Independent Editorial Digest

> About CJC-1295 Ipamorelin Reviews — an independent editorial project that summarizes the peer-reviewed CJC-1295 and ipamorelin literature in plain English. Not a clinic, not a vendor.

An independent editorial digest of the published literature. No clinic, no product, no prescription.

## What CJC + Ipa Reviews is

CJC + Ipa Reviews is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295 and ipamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

We took on this pairing for one reason: the gap between how confidently it is talked about online and how little of that talk is sourced. The fixed combination has a name, a following, and almost no primary literature of its own. So we went to the parts — the CJC-1295 pharmacokinetic studies, the ipamorelin selectivity work, the human GHRH-plus-GHRP synergy data — and translated them into plain English with every number cited.

## Why 'Reviews' does not mean what it might seem

The 'reviews' in our name is editorial framing — we *review the literature*. It is not a claim that we test products, rate vendors, or evaluate anyone's results. We hold a position relative to the published record, not relative to any marketplace. We do not review research-chemical suppliers, we do not link to them, and we take no position on where anything is obtained. Our entire subject is what the studies measured and where they stop.

That distinction matters because this is a research-only space. Neither peptide is FDA-approved, the fixed blend has never been clinically trialed, and we say so on every page rather than soften it.

## How we handle the science

Three rules govern everything here. First, every quantitative claim — every GH multiple, every half-life, every percentage — is tied to a specific study you can check on [the references page](/references). Second, we never give human dosing or medical advice; we report what was studied, in which species, by which route, and stop there. Third, we keep the honest framing structurally visible: where a claim comes from single-component data or general synergy theory rather than a trial of the blend, we say so plainly. The bright, energetic tone is deliberate — readable science should not have to be grim — but the accuracy underneath it is not negotiable.

---

A bright, fully-cited read of the CJC-1295 and ipamorelin literature — two emission lines, one honest gap where the fixed blend's trial should be; no clinic on the bench and nothing here dosed, mixed, prescribed, or sold.